O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
You must be a Standard 1 Year member to access this content.
FenXun Partners assisted JD.com on the deal. JD.com, executed the listing of its REIT, Harvest Jingdong Warehousing Logistics Close-end Infrastructure Securities Investment Fund, on the Shanghai...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
You must be a Standard 1 Year member to access this content.
Harneys and Tianyuan acted as Cayman Islands counsel to Gaush Meditech Limited, Tian Yuan Law Firm LLP, O’Melveny & Myers and Commerce & Finance Law Offices...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
You must be a Standard 1 Year member to access this content.
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited. O’Melveny & Myers represented Bio-heart on the deal. Huatai Financial Holdings (Hong Kong) Limited acted...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP advised Yonghe Medical on the deal. Yonghe Medical Group Co., Ltd. (2279.HK) announced its HK$1.49 billion (approximately US$192 million) initial public offering and...
You must be a Standard 1 Year member to access this content.
Harneys, Tian Yuan Law Firm LLC, and O’Melveny & Myers LLP acted for Gushengtang Holding Limited. Linklaters and Zhong Lun Law Firm assisted the joint sponsors....
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Morgan Stanley and CICC on the matter while O’Melveny & Myers and Maples and Calder represented Acotec Scientific Holdings Limited. The...
You must be a Standard 1 Year member to access this content.
